Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study-Reference-Cited by-同舟云学术

Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study

Published:2023-04 Issue: Volume:114 Page:103982
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Grebely Jason^ORCID,Gilliver Rosie,McNaughton Tony,Conway Anna^ORCID,Cunningham Evan,Henderson Charles,Hadlow Brett,Molloy Katrina,Doab Anna,Tillakeratne Shane,Pepolim Lucy,Harrod Mary Ellen,Dore Gregory J,Read Phillip

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference39 articles.

1. AIVL. (2006). A framework for peer education by drug user organisations. In AIVL (Ed.). Canberra, Australia.

2. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study;Bajis;Journal of Viral Hepatitis,2020

3. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia;Bajis;International Journal of Drug Policy,2018

4. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test;Bush;Archives of Internal Medicine,1998

5. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C;Castera;Gastroenterology,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions;Nature Reviews Gastroenterology & Hepatology;2024-08-15

2. A COMPARISON OF SOFOSBUVIR/VELPATASVIR (S/V) AND GLECAPREVIR/PIBRENTASVIR (G/P) FOR THE TREATMENT OF HCV INFECTION AMONG HCV-INFECTED PEOPLE WHO USE DRUGS (PWUD);Journal of Virus Eradication;2024-08

3. The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan;The Lancet Regional Health - Western Pacific;2024-07

4. Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers;International Journal for Equity in Health;2024-06-17

5. Peer support for people living with hepatitis B virus—A foundation for treatment expansion;Journal of Viral Hepatitis;2024-05-26